HEMISPHERX BIO (HEB)

BUYINS.NET Issues Hemispherx Biopharma SqueezeTrigger Report; Over 26 Million Shares Shorted in 2009; Next Short Squeeze Expected Above $1.13 11/23/2009 09:24:58 NEWPORT BEACH, Calif., Nov 23, 2009 (GlobeNewswire via COMTEX News Network) -- BUYINS.NET, www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics... The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc. 11/20/2009 18:00:55 NEW YORK, Nov 20, 2009 (GlobeNewswire via COMTEX News Network) -- The Brualdi Law Firm, P.C. announces that a lawsuit has been commenced in the United States District Court for the Eastern District... Hemispherx Biopharma Down 50.1% Since SmarTrend's Sell Recommendation 11/17/2009 10:29:07 Nov 17, 2009 (SmarTrend(R) Spotlight via COMTEX News Network) -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Hemispherx Biopharma (AMEX:HEB) on August 03, 2009 at... Class Action Lawsuit Against Hemispherx Biopharma is Without Merit 11/16/2009 08:45:17 PHILADELPHIA, Nov 16, 2009 (GlobeNewswire via COMTEX News Network) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") said the recently filed lawsuit is without merit. The lawsuit is... Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Hemispherx Biopharma, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the January 11, 2010 Lead Plaintiff Deadline 11/14/2009 09:12:20 BALTIMORE, MD, Nov 14, 2009 (MARKETWIRE via COMTEX News Network) -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District... More News